Blood Culture Tests Market Insights 2025-2034: Growth Forecast and Strategic Priorities

"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Blood Culture Tests Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for blood culture tests has noticeably expanded in the past few years. It is projected to increase from $6.79 billion in 2024 to $7.57 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%. The significant growth in the preceding period can be credited to the rise in infectious diseases prevalence, an aging population, progress in healthcare infrastructure, and an increase in research and development.

Blood Culture Tests Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market size for blood culture tests is anticipated to experience swift growth. It is projected to reach a value of $13.09 billion in 2029 with a compound annual growth rate (CAGR) of 14.7%. Several factors contribute to this expected growth during the forecast period, including an increase in hospital-acquired infections, a rise in demand for point-of-care (POC) testing, growth in healthcare spending, and regulatory authorizations. Trend forecasts for this period encompass the utilization of telemedicine and remote testing, automation and artificial intelligence, multiplex testing, sepsis management, and the monitoring of infectious diseases.

View the full report here:
https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report

What Are the Drivers Transforming the Blood Culture Tests Market?
The rise in occurrence of infectious diseases is projected to boost the growth of the blood culture test market. Pathogens such as viruses, bacteria, fungi, and parasites bring about infectious diseases which comprise of deadly microorganisms that intrude a person's body externally or through an infected individual. Diseases like COVID-19, tuberculosis, flu, measles, HIV, strep throat among others, can inflict temporary discomfort, severe tissue damage, even resulting in death. The World Health Organization lists infectious diseases as the world's second leading cause of death. The uptick in infectious diseases has heightened the need for blood culture tests to help diagnose if a patient is suffering from bacteremia/septicemia, a potential life-threatening condition. For instance, in the context of the UK, a report by the UK Health Security Agency in August 2024 stated that as of December 31, 2022, there existed 3,732 confirmed cases of mpox, the majority being in England. An additional 21 cases were reported by May 31, 2023, primarily in England and one case in Scotland. Hence, the escalating occurrence of infectious diseases is facilitating the growth of the blood culture test market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7763&type=smp

What Long-Term Trends Will Define the Future of the Blood Culture Tests Market?
Technological advancement is a prominent trend currently emerging in the blood culture tests market. Innovations and burgeoning global ties are opening up new opportunities in fields such as pharmaceuticals, biologics, nutraceuticals, and medical devices. The pressing need for manufacturers and producers to safely, swiftly and economically introduce new goods to the market, is driving them to develop top-of-the-range blood culture testing facilities in order to comply with progressively stringent standards. These technologies lessen expenses through precise, independent safety and performance validation. A case in point is in May 2022, when Labcorp, a testing laboratories firm in the US, unveiled its Labcorp OnDemandTM at-home collection kit. This kit, which uses a small blood sample to determine hemoglobin A1c (HbA1c) levels, applies dried blood technology to give a snapshot of the body's average blood glucose levels over a period. With this kit, individuals are able to regularly check their health from the convenience of their home using just a finger prick and a few blood drops.

Which Segments in the Blood Culture Tests Market Offer the Most Profit Potential?
The blood culture tests market covered in this report is segmented -

1) By Method: Conventional/Manual Methods, Automated Methods
2) By Product: Consumables, Instruments, Software and Services
3) By Technology: Culture-Based Technology, Molecular Technologies, Microarrays, PCR (Polymerase Chain Reaction), PNA-FiSH (Peptide Nucleic Acid - Fluorescent in Situ Hybridization), Proteomics Technology
4) By Application: Bacteremia, Fungemia, Mycobacterial Detection
5) By End User: Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories

Subsegments:
1) By Conventional/Manual Methods: Blood Culture Bottles (Aerobic and Anaerobic), Culture Media Preparation, Manual Observation and Identification
2) By Automated Methods: Automated Blood Culture Systems, Continuous Monitoring Systems, Integrated Identification and Sensitivity Testing Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7763&type=smp

Which Firms Dominate the Blood Culture Tests Market by Market Share and Revenue in 2025?
Major companies operating in the blood culture tests market include Becton, Dickinson and Company, BioMerieux SA, Thermo Fisher Scientific Inc., Luminex Corporation, Danaher Corporation, Terumo Corporation, Bruker Corporation, F. Hoffmann-La Roche AG, Biobase Biotech Co. Ltd., Scenker Biological Technology Co. Ltd., Bulldog Bio, Anaerobe Systems Inc., Himedia Laboratories Pvt. Ltd., Autobio Diagnostics Co. Ltd., Axiom Laboratories, Biosystems Inc., BINDER GmBH, Roche Diagnostics, Mikroscan Technologies Inc., Labotronics Ltd., Hardy Diagnostics, OpGen Inc., Meditech Technologies India Private Limited, Siemens Healthineers, Abbott Laboratories, Cepheid, T2 Biosystems Inc., Beckman Coulter Inc., Accelerate Diagnostics, Bio-Rad Laboratories Inc., Hologic Inc., Quidel Corporation, Copan Diagnostics Inc., Greiner Bio-One International GmbH, Carl Zeiss AG, Nanosphere Health Sciences, GenMark Diagnostics, Meridian Bioscience Inc., Nikon Corporation

Which Regions Offer the Highest Growth Potential in the Blood Culture Tests Market?
North America was the largest region in the blood culture tests market in 2024. The regions covered in the blood culture tests market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7763

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.